Papers

4

Total Citations

113

H-Index

4

About

Paul Kearns is a leading clinical researcher in urologic oncology, with a primary focus on improving surgical outcomes for prostate cancer. His work centers on radical prostatectomy, particularly comparing open, laparoscopic, and robot-assisted approaches to determine which yields the best oncological control and health-related quality of life. A key contribution is his analysis of positive surgical margins (PSMs), where his 2013 study of 2,385 patients from the Victorian Prostate Cancer Registry (49 citations) established critical benchmarks for margin rates and their impact on secondary treatment. He further advanced the field with a landmark 2015 comparison of open versus robot-assisted surgery (40 citations), providing population-based evidence on short-term outcomes. Kearns also contributed to large-scale Australian surgical audits, analyzing 2,943 laparoscopic cases, and explored cutting-edge technologies like 3D-printed patient-specific models to guide nerve-sparing procedures. His work has directly informed surgical decision-making and patient counseling, with his registry-based studies serving as foundational references for evidence-based practice in prostate cancer surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
113
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the <scp>P</scp> rostate <scp>C</scp> ancer <scp>R</scp> egistry
49 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Barwon Health, Prostate Cancer Foundation of Australia

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago